Folic Acid Protects Against Kidney Damage in Mice with Diabetic Nephropathy by Inhibiting M1 Macrophage Polarization

Insights

Folic acid (FA) protects against diabetic kidney disease by reducing inflammation and improving kidney function in mice. FA inhibits M1 macrophage polarization, a key factor in diabetic nephropathy (DN) pathogenesis.

Area of Science:

  • Nephrology
  • Immunology
  • Endocrinology

Background:

  • Diabetic nephropathy (DN) is a major complication of diabetes, characterized by kidney damage and inflammation.
  • Macrophage infiltration and polarization are critical in DN pathogenesis.
  • Folic acid (FA) is known to modulate inflammatory responses by regulating macrophage polarization.

Purpose of the Study:

  • To investigate the protective effects of folic acid (FA) on kidney injury in a mouse model of diabetic nephropathy (DN).
  • To elucidate the underlying mechanisms of FA's action, particularly concerning macrophage polarization and inflammatory pathways.

Main Methods:

  • Diabetic nephropathy was induced in mice, followed by treatment with folic acid (FA).
  • Renal function, metabolic parameters, and kidney structural damage were assessed.
  • Macrophage infiltration (M1 phenotype) and inflammatory markers were analyzed in renal tissues and in vitro cell models (RAW264.7 cells) exposed to high glucose.
  • NF-kB signaling pathway activation was evaluated.

Main Results:

  • FA treatment improved metabolic parameters (food/water intake, urine volume, body weight, serum insulin) and ameliorated renal functional and structural damage in DN mice.
  • FA significantly reduced M1 macrophage infiltration and inflammatory cytokine levels in the kidneys.
  • In vitro, FA inhibited high glucose-induced M1 macrophage polarization and inflammatory factor production, including p-p65/p65 expression, suggesting NF-kB pathway involvement.

Conclusions:

  • Folic acid (FA) demonstrates protective effects against kidney damage in diabetic nephropathy (DN).
  • FA exerts its renoprotective effects by inhibiting M1 macrophage polarization.
  • The mechanism may involve the suppression of the nuclear factor-kappa B (NF-kB) signaling pathway.